Troy Wichterman
Chief Financial Officer, BioLife Solutions
Replay available
BioLife Solutions, Inc. (NASDAQ: BLFS) Q4 2025 earnings conference call, held 2026-02-26. Replay captured from the company's public earnings webcast.

Chief Financial Officer, BioLife Solutions
Chairman and Chief Executive Officer, BioLife Solutions
Analyst, Jefferies
Analyst, KeyBank Capital Markets
Analyst, TD Cohen
Analyst, Stevens
Analyst, Craig-Hallum Capital Groups
Analyst, Northland Capital Markets
Analyst, Maxim Group
Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Q4 2025 Shareholder and Analyst Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. I would now like to turn the call over to Troy Wichterman, Chief Financial Officer of BioLife Solutions. Please go ahead. Thank you, Operator. Good afternoon, everyone, and thank you for joining the BioLife Solutions 2025 Fourth Quarter Earnings Conference Call. On this call, we will cover business highlights, financial performance for the fourth quarter and full year 2025, and provide 2026 financial guidance. Earlier today, we issued a press release announcing our financial results and operational highlights for the fourth quarter and full year of 2025 and provided 2026 financial guidance, which is available at biolifesolutions.com. As a reminder, during this call, we will make forward-looking statements. These statements are subject to risks and uncertainties that can be found in our SEC filings. These statements speak only as of the date given, and we undertake no obligation to update them. Unless otherwise noted, all financial measures discussed reflect non-GAAP or adjusted results. Reconciliations of GAAP to non-GAAP or adjusted financial metrics are included in a press release we issued this afternoon. Now, I'd like to turn the call over to Rod DeGrief, Chairman and CEO of BioLife. Thanks, Troy. Hi. Good afternoon and thank you for joining us for BioLife's fourth quarter and full year 2025 conference call. 2025 was another strong year for BioLife, delivering double-digit revenue growth, operating margin expansion, and improved profitability. Throughout the year, we executed consis...